Scheidbach H, Schneider C, Huegel O, Bärlehner E, Konradt K, Wittekind C, Köckerling F
Department of Surgery and Center for Minimally Invasive Surgery, Hannover Hospital, Siloah, Hannover, Germany.
Dis Colon Rectum. 2002 Dec;45(12):1641-7. doi: 10.1007/s10350-004-7252-3.
Despite reservations about compliance with oncologic radical criteria, laparoscopic resection of the sigmoid colon is increasingly being used with curative intent in oncologic surgery of the colorectum. The aim of the present study was to obtain further information on the perioperative course, the oncologic radicalness of the procedure, and medium-term outcome.
The data presented here were obtained from a prospective, multicenter study conducted in Germany and Austria. These data were acquired from an analysis of subgroups derived from a total of 3,133 recruited patients.
A total of 292 patients from 36 hospitals underwent laparoscopic resection of the sigmoid colon with curative intent. The definitive histopathologic work-up of surgical specimens revealed the following International Union Against Cancer tumor stages: 122 Stage I, 86 Stage II, and 84 Stage III. The mean operating time was 172 minutes, and the mean intraoperative blood loss was 241 ml. The conversion rate to open surgery was 5.5 percent, the majority of such conversions being made necessary by vascular lesions. Sixty-five of the patients reported at least one postoperative problem or complication (22.3 percent); the mortality rate was 2.7 percent. With a mean of 13.4 recovered lymph nodes and a mean aboral safety margin of 72 mm, the formal criteria for the assessment of oncologic radicalness were met. Intraoperative cell dissemination occurred in two patients. The long-term results, which, at a mean follow-up of 2.1 years and a follow-up rate of 73.3 percent, must be considered preliminary, show a calculated stage-related survival rate of 88.8, 90.9, and 64.1 percent, respectively, for the International Union Against Cancer Stages I, II, and III.
Laparoscopic sigmoid resection can be performed technically reliably-also with curative intent-with acceptable complication and mortality rates and, to date, with survival rates that are at least comparable with those achieved with open surgical procedures.
尽管对是否符合肿瘤根治标准存在保留意见,但在结直肠癌肿瘤手术中,腹腔镜乙状结肠切除术越来越多地被用于根治性目的。本研究的目的是获取关于围手术期过程、手术的肿瘤根治性以及中期结果的更多信息。
此处呈现的数据来自于在德国和奥地利进行的一项前瞻性多中心研究。这些数据是通过对总共3133名招募患者的亚组分析获得的。
来自36家医院的292例患者接受了根治性腹腔镜乙状结肠切除术。手术标本的最终组织病理学检查显示了以下国际抗癌联盟肿瘤分期:122例I期,86例II期,84例III期。平均手术时间为172分钟,平均术中失血量为241毫升。转为开放手术的比例为5.5%,大多数此类转换是由血管病变导致的。65例患者报告了至少一种术后问题或并发症(22.3%);死亡率为2.7%。平均回收淋巴结13.4个,平均远切缘安全距离为72毫米,符合肿瘤根治性评估的正式标准。两名患者术中出现癌细胞播散。平均随访2.1年,随访率为73.3%,长期结果必须被视为初步结果,显示国际抗癌联盟I期、II期和III期的计算分期相关生存率分别为88.8%、90.9%和64.1%。
腹腔镜乙状结肠切除术在技术上可以可靠地进行——也用于根治性目的——并发症和死亡率可接受,并且迄今为止,生存率至少与开放手术相当。